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Abstract 
 
Forkhead box g1 (Foxg1) is a nuclear-cytosolic transcription factor essential for the forebrain 
development and involved in neurodevelopmental and cancer pathologies. Despite the 
importance of this protein, little is known about the modalities by which it exerts such a large 
number of cellular functions. Here we show that a fraction of Foxg1 is localized within the 
mitochondria in cell lines, primary neuronal or glial cell cultures, and in the mouse cortex. 
Import of Foxg1 in isolated mitochondria appears to be membrane potential-dependent. 
Amino acids (aa) 277–302 were identified as critical for mitochondrial localization. 
Overexpression of full-length Foxg1 enhanced mitochondrial membrane potential (ΔΨm) 
and promoted mitochondrial fission and mitosis. Conversely, overexpression of the C-term 
Foxg1 (aa 272–481), which is selectively localized in the mitochondrial matrix, enhanced 
organelle fusion and promoted the early phase of neuronal differentiation. These findings 
suggest that the different subcellular localizations of Foxg1 control the machinery that brings 
about cell differentiation, replication, and bioenergetics, possibly linking mitochondrial 
functions to embryonic development and pathological conditions. 
 
  
Forkhead box g1 (Foxg1; formerly known as BF-1, qin, Chicken Brain Factor 1, or XBF-1 
and renamed Foxg1 for mouse, FOXG1 for human, and FoxG1 for other chordates) (1) is an 
evolutionary conserved transcription factor belonging to the forkhead box family, named 
after the first member, forkhead, discovered in Drosophila (2). In vertebrates, Foxg1 is 
essential for the development of telencephalon, cell migration, and cerebral cortex patterning 
and layering (3, 4). During early phases of cortical development, Foxg1 controls the rate of 
neurogenesis by keeping progenitor cells in a proliferative state and by inhibiting their 
differentiation into neurons (5). Its action is also necessary for the correct formation of the 
inner ear, the olfactory system (6, 7), and the proper axonal growth in the developing retina 
(8). A further functional role of Foxg1 concerns its capability to inhibit cell death in rat 
cerebellar culture primed to undergo apoptosis, whereas suppression of Foxg1 expression 
induces apoptosis in healthy neurons (9). 
The intracellular localization of Foxg1 is controlled posttranslationally (10), and it alternates 
between the nucleus and the cytoplasm. Specifically, Foxg1 is confined predominantly in the 
nucleus in areas of active neurogenesis of the developing mouse brain, whereas cytoplasmic 
localization correlates with early neuronal differentiation areas (10). In the nucleus, Foxg1 
operates as a transcriptional repressor; the targets identified include FGFs (fibroblast growth 
factors), Shh (sonic hedgehog homolog), and cell-cycle inhibitors such as p21Cip1 (11). In the 
cytoplasm, Foxg1 works as a TGF-β inhibitor by binding to Smad3 (mothers against 
decapentaplegic homolog 3) (12). 
Deregulation or mutations of FOXG1 have been identified in several important human 
diseases, including different types of cancer (11, 13, 14), neurodevelopmental disorders such 
as Rett syndrome (RS) (15, 16), and other autism spectrum disorders (17). 
Notwithstanding the key role of Foxg1 in maintaining the correct balance among cell 
replication, differentiation, and apoptosis, the mechanisms coordinating these fundamental 
events are largely unknown. 
In the present study we demonstrate, in isolated mitochondria, cell lines, primary cell 
cultures, and mouse cortical extracts, that a fraction of Foxg1 localizes in the mitochondrial 
matrix and that a unique domain located between amino acids (aa) 277 and 302 is responsible 
for its mitochondrial targeting. We demonstrate that full-length, mitochondrial, and cytosolic 
forms of Foxg1 affect cell growth, differentiation, and mitochondrial functions. 
Mitochondria control fundamental processes in neuro development and neuroplasticity, 
including the differentiation of neurons, the growth of axons and dendrites, and the formation 
and reorganization of synapse (18, 19). Our findings reveal a previously unknown 
mitochondrial localization and function of Foxg1, suggesting this transcription factor may 
represent a key link among mitochondrial function, neuronal differentiation, and potentially, 
important pathological conditions such as RS and cancer. 
  
Results 
 
A Fraction of Endogenous Foxg1 Colocalizes with Mitochondria.  
Fig. 1 shows that, using a highly specific anti-Foxg1 antibody (Ab), a discrete cytoplasmic 
granular staining can be observed in the hippocampal HN9.10e cell line and in primary glia. 
To characterize the localization of Foxg1, mitochondria, lysosomes, and Golgi apparatus 
were investigated by using Abs or specific markers (Fig. 1 and Fig. S1B). Double 
immunofluorescence labeling was performed with Abs directed against Foxg1 and the 
mitochondrial marker superoxide dismutase 2 (Sod2). Colocalization in HN9.10e cells was 
quantified using Manders’ coefficients (20). A partial but clear colocalization between 
endogenous Foxg1 and Sod2 was observed in HN9.10e cells (MFoxg1 = 61%; Fig.1 A and D) 
and primary glia (MFoxg1 = 38%). Conversely, neither lysosomes nor Golgi show any 
colocalization with Foxg1 (Fig. S1B). The nature of nonmitochondrial and nonnuclear 
Foxg1-positive regions is at present unclear, but most likely it is represented by 
cytoplasmatic Foxg1. To verify this unexpected mitochondrial localization of a double 
immunofluorescence with anti-Foxg1 and anti-Sod2, Abs was performed on both HN9.10e 
cells and primary glia overexpressing Foxg1. In these conditions (Fig. 1 B and C), although a 
majority of the protein is still localized in the nucleus, the specific Foxg1 mitochondrial 
signal is clearly enhanced both in HN9.10e (MFoxg1 = 80%; Fig.1E) and in primary glia (MFoxg1 
= 79%; Fig. 1F). 
Nuclear and Mitochondrial Localization of Foxg1-GFP.  
Foxg1 fused to GFP both at the N terminus (GFP-Foxg1) and at the C terminus (Foxg1-GFP) 
was transfected in cell lines and primary mouse cortical cultures (Fig. 2 and Fig. S1A). 
Foxg1-GFP localized both in the nucleus and in mitochondria (Fig. 2A); conversely, as 
already reported by different groups including us (16), GFP-Foxg1 showed an exclusive 
nuclear localization (Fig. 2B and Fig. S1A). We also fused Foxg1 with CFP and YFP at the N 
and C terminus, respectively. HN9.10e cells transfected with this construct (Fig. 3A) show 
the contemporary presence of CFP and YFP only in the nucleus; a proportion of cells (∼10%) 
show the presence of YFP, but not CFP, in mitochondria. These data suggest that a 
proteolytically cleaved form of the chimeric protein, with removal of the CFP-tagged N 
terminus, can interact with (or is imported into) mitochondria. 
To further confirm the hypothesis of a Foxg1 proteolytic cleavage, we performed Western 
blot (WB) experiments on NIH 3T3 cell line transiently expressing GFP-Foxg1 or Foxg1-
GFP harvested 24 or 48 h after transfection and probed with Abs against Foxg1 C terminus 
(Fig. 3). Fig. 3B shows, both in the GFP-Foxg1- and in the Foxg1-GFP-expressing cells, a 
major immunoreactive band at ∼95 kDa, compatible with the expected molecular weight 
(MW) of the uncleaved fusion protein. In Foxg1-GFP-expressing cells, there is an additional 
strongly immunoreactive band of ∼70 kDa compatible with the removal of an N-terminal 
fragment of about 25 kDa. In GFP-Foxg1-expressing cells probed with anti-Foxg1, a strongly 
positive band of ∼45–50 kDa is labeled, compatible with the removal of a GFP-tagged N 
terminus fragment of ∼25 kDa (Fig. 3B and Fig. S2A). In controls and transfected cells, two 
additional weak bands are clearly visible with MW ∼58 and ∼50 kDa. The bands at 95 and 
70 kDa from cells expressing Foxg1-GFP, and at ∼95 kDa from cells expressing GFP-Foxg1, 
when probed with an anti-GFP Ab, appeared positive for the tag. Of interest (Fig. 3B, right 
lane), when Foxg1-GFP-expressing cells were harvested 48 h after transfection, in addition to 
the 95- and 70-kDa bands, a new specific band of ∼45 kDa was labeled by anti-Foxg1 Ab. 
 
The question arises as to the possibility that this complex proteolytic processing could be an 
artifact of the Foxg1 fusion with GFP. Fig. 3C shows the results of WB performed with anti-
Foxg1 on controls and cells overexpressing untagged Foxg1. Twenty-four hours after 
transfection, two main bands of ∼58 and ∼45 kDa are recognized in Foxg1-overexpressing 
cells, presumably corresponding to the ∼95- and ∼70-kDa bands of the GFP-tagged Foxg1-
expressing cells. In controls, three bands were revealed by the anti Foxg1 Ab, with MW of ∼58, ∼50, and ∼45 kDa. The relative intensities of the three bands were significantly 
different in controls and Foxg1-overexpressing cells. In controls, the 58 kDa is weak, and the 
most abundant one is of ∼50 kDa; a ∼45-kDa band was revealed only when overexposing the 
gel (Fig. S2B). Forty-eight hours after transfection, in Foxg1-overexpressing cells, a ∼24-
kDa band becomes evident (Fig. 3C), presumably corresponding to the ∼50-kDa band 
recognized in the lysate of cells expressing Foxg1-GFP (Fig. 3B). This band was never 
observed in control NIH 3T3 cells; however, it was clearly visible in untransfected HN9.10e 
cells (Fig. S3), as well as in the mitochondrial fraction from mouse brain (Fig. 4B). 
Comparison between controls and overexpressing cells reveals that in the latter case, the 
processing of the transfected Foxg1 is quantitatively different from that of their controls, but 
more similar to that observed in a neuronal cell line, HN9.10e, and in the mouse brain (i.e., 
cells and tissues in which the endogenous level of Foxg1 is much higher than in NIH 3T3 
fibroblast line). 
Foxg1 Mitochondrial Localization Domain.  
An in silico analysis of the protein sequence using the MitoProt II algorithm 
(https://ihg.gsf.de/ihg/mitoprot.html) predicted aa 264–313 to be a mitochondrial targeting 
sequence if located N terminally, with a probability of 96%. To test this prediction, and to 
identify the minimum domain sufficient for the Foxg1 mitochondrial localization, we 
generated several Foxg1 fusion proteins by progressive 5  and 3  deletions around aa 264–
313, carrying GFP at the C terminus (Fig. S4A). The constructs were transfected in NIH 3T3 
cells, and the ability of the resulting peptides to drive GFP to mitochondria was evaluated by 
confocal microscopy (Fig. S4B). These data indicate that aa 277–302 are essential for Foxg1 
mitochondrial localization. 
Import Assay of Foxg1 into Isolated Rat Liver Mitochondria.  
Full-length Foxg1 and its 272–481 fragment, along with control localization proteins, were in 
vitro transcribed and translated in a rabbit reticulocyte lysate in the presence of 
[35S]methionine (TnT). The in vitro transcription resulted in the production of two 
predominant 35S-labeled polypeptides with the expected MW of 58 or 25 kDa from, 
respectively, the full-length Foxg1 and the 272–481 fragment (Fig. 4A). After incubation of 
the in vitro-produced protein with rat liver mitochondria for 60 min in the presence of 
succinate and ATP, a significant amount (23.6 ± 4.4%) of the total in vitro translated Foxg1 
protein (whole lane signal) survived trypsin treatment. In particular, 5.4 ± 1.2% of the full-
length Foxg1 protein survived the trypsin treatment (Fig. 4A, control). When mitochondria 
were pretreated with the uncoupler carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone 
(FCCP), no trypsin-resistant band was found (0.3 ± 0.1% for the whole lane; Fig.4A, FCCP). 
Three additional bands (of about 49, 45, and 24 kDa) appear partially resistant to trypsin, but 
only in the absence of FCCP. Such bands represent 5.3 ± 0.9%, 7.5 ± 1.5%, and 6.4 ± 1.5% 
of the total in vitro translated Foxg1 protein, respectively. Incubation of the full-length 
protein with mitochondria also produced a band of ∼42 kDa, either in the presence or 
absence of FCCP; this 42-kDa band is sensitive to trypsin and may depend on proteolytic 
cleavage outside the mitochondria. 
The import assays were performed in parallel with three control proteins; namely, the 
mitochondrial TFAM (mitochondrial transcription factor A), the nuclear TMCO1 
(transmembrane and coiled-coil domains 1), and the cytoplasmic GAPDH (glyceraldehyde 3-
phosphate dehydrogenase) (Fig. S5). Under the experimental conditions used, TFAM was 
very efficiently imported (71.2 ± 1.8% band signal resistant to trypsin), as expected, whereas 
no evidence for mitochondrial import was found for TMCO1 and GADPH (0.05 ± 0.01% 
appears trypsin-resistant). 
Regarding the 272–481 fragment (Fig. 4A), 4.4 ± 0.6% (of the total protein added) survived 
trypsin digestion, but only in the absence of FCCP (0.1 ± 0.1%, in its presence). As expected, 
no band was observed, in the absence or presence of the uncoupler, on lysis of mitochondria 
with Triton ×100. 
In conclusion, the in vitro import assay indicates that mitochondria are able to import Foxg1 
in a membrane potential-dependent process, with the generation of peptides with a MW 
lower than that of the full-length protein. A fraction of full-length Foxg1 also appears 
resistant to trypsin, suggesting the intact protein can be imported as such. 
Foxg1 Localization in Isolated Mitochondria from Newborn Mouse Cortex.  
To verify our findings in more physiological conditions, we investigated the protein 
localization in newborn (P1-2) mouse cortex. As indicated in Fig. 4B, the anti-Foxg1 Ab 
revealed, in the nuclear fraction, exclusively a 58-kDa band, and in the cytosolic fraction, 
predominantly a 45-kDa band and a small amount of the 58-kDa band. In the mitochondrial 
fraction, both the 58- and 45-kDa bands and a further 24-kDa band were exclusively visible 
in this fraction. Trypsin digestion of the mitochondrial fraction led to the complete 
degradation of the 58-kDa Foxg1 band, whereas the 45- and 24-kDa bands were resistant to 
the proteolytic degradation and only disappeared on mitochondrial lysis with SDS. This latter 
result suggests that both the 45- and 24-kDa truncated forms are inside the mitochondria. The 
purity of the subcellular fractions was controlled by stripping and reprobing the filter with 
Abs against Neu-N, Sod2, and GAPDH or tubulin. 
Foxg1 Submitochondrial Localization in Living Cells.  
The mitochondrial localization of Foxg1 was further investigated in NIH 3T3 cells 
expressing Foxg1-GFP, using the approach described by Giacomello et al. (21) (Fig. S6 A 
and B). Transfected cells permeabilized with digitonin were treated with trypan blue, a strong 
fluorescence quencher able to cross the nuclear and the outer mitochondrial membrane 
(OMM), but not the inner one. Upon trypan blue addition, the GFP signal was rapidly and 
totally quenched in the nucleus, whereas only ∼30% of mitochondrial fluorescence decrease 
was observed; this demonstrates that a fraction of Foxg1-GFP is present either on the OMM 
or/and in the intermembrane space (∼30%), whereas the majority (∼70%) appears to be 
located in a trypan blue-inaccessible compartment (i.e., the matrix) (21). Consistent results 
were obtained using proteinase K, a nonspecific serine protease that can traverse nuclear 
pores but not the OMM (Fig. S6 C and D). Also, in this case, ∼30% of the mitochondrial 
signal was sensitive to the protease. These results, in agreement with the WB experiments on 
mitochondrial fractions, show that a fraction of Foxg1-GFP is imported into the 
mitochondrial matrix, whereas a small fraction is bound to the cytoplasmic surface of the 
OMM, and is thus sensitive to the protease or to trypan blue. 
Foxg1, Mitochondrial Shape, and Cellular Proliferation.  
Mitochondrial morphology is critical for a number of cellular processes and depends on the 
dynamic balance between fusion and fission (22). HN9.10e cells were cotransfected with 
GFP and full-length Foxg1 (FL-Foxg1), Foxg1 272–481 (mt-Foxg1), or Foxg1 315–481 (cyt-
Foxg1), a fragment missing the mitochondria-targeting sequence and displaying a diffused 
intracellular localization (Fig. 5A), and the mitochondrial morphology was evaluated. 
Mitochondria, as revealed by tetramethylrhodamine-methyl ester (TMRM) loading, were 
arbitrarily divided into three subclasses: shorter than 2 μm, between 2 and 4 μm, and longer 
than 4 μm. The overexpression of cyt-Foxg1 did not result in any significant change in 
mitochondrial morphology compared with controls, whereas the overexpression of FL-Foxg1 
caused an increased number of mitochondria shorter than 2 μm and a reduction of 
mitochondria belonging to the second and the third class, respectively. In contrast, the 
overexpression of mt-Foxg1 induced a slight, but significant, increase in the proportion of 
mitochondria longer than 4 μm (Fig. 5B). 
In parallel, the proliferative state of the same transfected cells was morphologically evaluated 
(23). HN9.10e cells are normally round-shaped, but respond to differentiation stimuli by 
emitting filopodia. This allowed us to divide transfected cells into three classes: mitotic cells 
(plasma membrane birefringence in transmitted light), blasts (round-shaped cells with 
epithelioid appearance), and cells with filopodia. Data presented in Fig. 5C indicate that the 
overexpression of cyt-Foxg1 did not cause significant changes in the distribution of cells 
between the three classes compared with controls. The overexpression of FL-Foxg1 enhanced 
the percentage of mitotic cells and reduced blasts and early differentiating cells. The 
expression of mt-Foxg1 had an opposite effect: a slight, but significant, increase in the 
proportion of early differentiating cells. 
Foxg1, Mitochondrial Membrane Potential, and Cellular Respiration.  
We next evaluated the effect of Foxg1 overexpression on mitochondrial TMRM 
accumulation. To this end, HN9.10e cells were cotransfected with GFP and FL-Foxg1, mt-
Foxg1 (272–481), or cyt-Foxg1 (315–481), and were finally loaded with TMRM (Fig. 6A). 
As shown in Fig. 6B, TMRM accumulation was enhanced by overexpression of FL-Foxg1, 
whereas that of mt-Foxg1 caused only a minor increase, and cyt-Foxg1 had no effect. 
Addition of the mitochondrial ATPase inhibitor oligomycin increased TMRM accumulation, 
as expected. However, although the drug increased TMRM fluorescence by ∼20% in 
controls, cyt-Foxg1, and mt-Foxg1, it hardly changed this parameter in FL-Foxg1 
overexpressing cells. 
To further assess the role of Foxg1 in regulating mitochondrial function, we measured the 
oxygen consumption rate (OCR) of HN9.10e cells transfected with FL-Foxg1, mt-Foxg1, or 
cyt-Foxg1 (Fig. 6 C–E). Oligomycin treatment revealed that the ATP synthesis-linked 
oxygen consumption was only slightly decreased in FL-Foxg1-expressing cells in 
comparison with untransfected cells and was not significantly different from that of cells 
expressing the cytosolic or mitochondria-targeted Foxg1. However, the overexpression of 
both FL-Foxg1 and mt-Foxg1 had a strong effect on the respiratory reserve capacity (as 
revealed by FCCP addition), completely abolishing it. 
  
Discussion 
 
In the present study, we demonstrate, in isolated rat mitochondria, cell cultures, and mouse 
cortex, that Foxg1 is imported into mitochondria in an energy-dependent manner and that it 
modulates cellular and mitochondrial functions such as proliferation, differentiation, 
mitochondrial membrane potential (ΔΨm), and OCR. The presence in mitochondria of 
transcription factors having a major role in neuronal survival, differentiation, and plasticity is 
an established, yet intriguing, notion that underlines the interplay among mitochondrial, 
nuclear, and cellular functions. Examples are the cAMP response element-binding protein 
(24) and p53 (25), as well as FOXO3a and FoxP2, members, such as Foxg1, of the Forkhead 
family (26, 27). 
Here we directly demonstrate that a fraction of Foxg1 is recruited to mitochondria, showing 
that both endogenous Foxg1 and overexpressed Foxg1-GFP colocalize with mitochondrial 
markers in cell lines, primary cells, and mouse cortex. We also demonstrate that a Foxg1 
272–481-GFP chimera displays an exclusive and unequivocal mitochondrial localization. 
Thus, Foxg1 lacks the classical N-terminal mitochondrial targeting sequence but possesses an 
internal one placed downstream its forkhead domain, as suggested by in silico analysis. 
The data obtained in the subcellular fractionation experiments clearly demonstrate that within 
mitochondria of living cells (mouse brain or HN9.10e cells), there is no full-length Foxg1, 
but only C-terminal fragments of the protein. Using an in vitro mitochondrial import assay, 
however, a fraction of in vitro synthetized full-length Foxg1 appears to be trypsin-resistant, 
indicating it has been imported by mitochondria (in the matrix or in the intermembrane 
space) through a membrane potential-dependent process. The simplest explanation is that 
Foxg1 is imported, at least in part, as intact full-length protein, and then is completely 
cleaved into smaller fragments within the matrix. Accordingly, in living cells, the amount of 
full-length Foxg1 within mitochondria is expected to be negligible. The absence of 
mitochondria labeled with GFP when transfected with GFP-Foxg1 suggests that fusion of 
GFP at the Foxg1 N terminus interferes with the mitochondrial import 
machinery/recognition. If this were not the case, and GFP-Foxg1 imported as such and then 
cleaved in the matrix or in the intermembrane space, GFP should remain trapped within 
mitochondria. However, as indicated by the experiments carried out with the double-tagged 
Foxg1, remova of the CFP-tagged N terminus of Foxg1 in the cytosol allows the 
mitochondrial import of the C-terminal, and thus labeling of mitochondria with YFP. 
In conclusion, Foxg1 undergoes a complex and relatively slow posttranslational processing, 
with slight variations depending on the cell type. The 58-kDa FL-Foxg1, the primary 
localization of which is in the nucleus and in the cytoplasm, can be imported as such into the 
mitochondria and then further proteolized within the matrix; the full-length protein can be 
also partially proteolized in the cytoplasm with the generation of a 45-kDa fragment that in 
part remains in this compartment, and in part is imported into mitochondria. The 24-kDa C-
terminal fragment of Foxg1 is exclusively produced within mitochondria. 
During development, Foxg1 exerts a dual role, promoting proliferation of telencephalic 
neuroepithelial cells and inhibiting their premature differentiation. In HN9.10e cells, a model 
line for neuronal differentiation, we found a clearly different proliferation/differentiation-
inducing activity of overexpressed FL-Foxg1 (both nuclear and mitochondrial), mt-Foxg1 
(exclusively mitochondrial), and cyt-Foxg1 (displaying a diffuse intracellular localization). 
Whereas FL-Foxg1 promotes mitochondrial fission and cellular proliferation, mt-Foxg1 
favors mitochondrial fusion and an early phase of neuronal differentiation. It is noteworthy 
that extensively interconnected mitochondrial networks are frequently found in metabolically 
active cells, whereas mitochondrial fission occurs during cytokinesis and apoptosis (22). 
These results suggest that Foxg1, through its internal processing and its mitochondrial 
targeting, participates in the regulation of the correct proliferation/differentiation balance of 
neuroepithelial cells. 
In addition, our results indicate that overexpressed FL-Foxg1 enhances ΔΨm and decreases 
the respiratory reserve capacity of mitochondria. The increased ΔΨm, together with almost 
blunted mitochondrial reserve capacity in FL-Foxg1 overexpressing cells, is in agreement 
with their high proliferative phenotype. Indeed, fast proliferating cells, despite having fully 
functional respiratory complexes, are highly glycolytic regardless of O2 availability, often 
displaying higher ΔΨm in comparison with their differentiated counterpart. Moreover, it has 
been shown that respiration is at near-maximum capacity for human pluripotent stem cells, in 
contrast to, for example, fibroblasts, which have a large, untapped respiratory reserve 
capacity (ref. 28 and references therein). With progressive cellular differentiation, highly 
proliferative cells shift metabolism from glycolysis to oxidative phosphorylation. 
Modifications of Foxg1 expression have been linked to human pathologies, such as RS (15, 
29), autism spectrum disorders (17), and different types of cancer (11, 13). The notion that 
mitochondrial abnormalities may play a role in RS predates the discovery of its genetic origin 
(30), and to our knowledge, there is no previous report showing a direct mitochondrial 
localization of any of the proteins linked to RS (MeCP2, CDKL5, FOXG1) so far identified. 
The newly discovered Foxg1 mitochondrial localization may provide novel insights into the 
manifestation of RS symptoms. 
Finally, it is known that both up-regulation and down-regulation of FOXG1 are linked to 
cancer progression. The first link between FOXG1 (in that context named quin) and cancer 
was published in 1993, demonstrating that FOXG1 can act as a potent oncogene (14). More 
recently, it was demonstrated that in glioblastoma, FOXG1 overexpression suppresses the 
transcription of p21Cip1 and causes abnormal cellular proliferation and worse prognosis (11). 
Conversely, in breast cancer, low levels of FOXG1 are correlated with a worse prognosis, as 
it increases the expression of the AIB1 oncogene (31). It is tempting to speculate that a 
variable intracellular localization of Foxg1 in these different conditions may contribute to 
explain these apparently contradictory findings. An amount of recent evidence suggests that 
metabolism and mitochondrial functions play a critical role in cancer development and 
progression (32). The identification of the multiple localization of Foxg1 (nucleus, cytosol, 
and mitochondrial matrix) opens the way to study the mechanisms exploited by this protein 
to tie together gene expression, metabolism, and mitochondrial bioenergetics. 
 
 
 
  
Materials and Methods 
 
Plasmid Construction.  
All the constructs present in this report have been generated by standard PCR strategy (SI 
Experimental Procedures). 
Cell Culture and Transfection.  
The cell lines were cultured according to ATCC (American Type Culture Collection) 
guidelines and transfected with Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s instructions. 
Immunocytofluorescence.  
Cells were seeded on gelatin-coated glass coverslips and transiently transfected with suitable 
plasmids. Twenty hours after transfection, cells were fixed with 4% (vol/vol) 
paraformaldehyde, permeabilized with 0.05% Triton X-100, and after blocking with 1% FBS, 
incubated with a rabbit polyclonal anti-Foxg1 Ab (ABCAM ab18259) or a mouse 
monoclonal anti-Sod2 (Invitrogen A21990). Cells were than incubated with the appropriate 
secondary Ab. 
In Vivo Fluorescence Imaging.  
All imaging experiments were performed on a Leica TCS SL confocal microscope equipped 
with Leica oil immersion HCX PL Apo 63X, 1.4 N.A. or Leica HCX PL Apo 40X, 1.25–0.75 
N.A. objectives at 37 °C. 
Western Blot on Transfected Cells and Mouse Cortex.  
Whole cortices of P1/2 newborn animals were carefully dissected and homogenized using a 
Teflon–glass homogenizer; cytoplasm, nucleus, and mitochondria were isolated by 
differential centrifugations. Samples were than prepared for WB assay (for details, see SI 
Experimental Procedures). 
Import Assay of Full-length Foxg1 into Isolated Rat Liver Mitochondria.  
Amplified cDNAs corresponding to full length or aa 272–481 were used to generate 
[35S]methionine-labeled proteins. Labeled proteins were incubated with isolated rat liver 
mitochondria for 1 h at 37 °C (33) in the presence or absence of FCCP to dissipate the ΔΨm. 
Trypsin was added to digest proteins outside mitochondria. For details, see SI Experimental 
Procedures. 
Measure of OCR.  
To measure OCR, 6 × 104 HN9.10e cells were transfected (or not) with FL-Foxg1, mt-Foxg1 
(272–481), or cyt-Foxg1 (315–481) and simultaneously plated onto XF24 plates (Seahorse 
Bioscience); cells were incubated at 37 °C, 5% CO2, and the medium was replaced 1 h after 
transfection. Twenty-four hours later, the medium was replaced with 675 μL unbuffered 
assay media (DMEM base, Sigma D5030, supplemented with 1.85 g/L NaCl, 1 mM Na-
pyruvate, 2 mM glutamine, and 25 mM glucose at pH 7.4), and cells were placed at 37 °C in 
a CO2-free incubator. Basal OCR was recorded using the XF24 plate reader. During the 
experiment, cells were challenged with oligomycin (1 μM) or FCCP (0.2 and 0.4 μM), and at 
the end of the experiment, rotenone (1 μM) + antimycin A (1 μM) were added to measure 
mitochondria-independent OCR. Each cycle of measurement consisted of 3 min mixing, 3 
min waiting, and 3 min measuring. For each well, the mitochondrial-dependent OCR (i.e., the 
rotenone/antimycinA-sensitive respiration) was normalized to OCR upon 
rotenone/antimycinA (nonmitochondrial OCR). 
Evaluation of ΔΨm, Mitochondrial Morphology, and Cellular Proliferation.  
HN9.10e cells were plated on glass coverslips and transfected with GFP or cotransfected with 
GFP and untagged FL-Foxg1, mt-Foxg1 (272-481), or cyt-Foxg1(315-481) at a 1:5 ratio; 24 
h later, cells were loaded with 2 nM TMRM (Life Technologies) and imaged. Evaluation of 
ΔΨm was carried out by specific MatLab routines (MatLab software). Mitochondrial length 
was calculated using Mytoe, a free software generated for the automated analysis of the 
mitochondrial morphology and dynamics (34). Cellular proliferation was evaluated 
morphologically according to Dotti et al. (23). 
Statistical Analysis.  
All statistical analyses were performed y using OriginPro 7.5 (OriginLab Corporation). Data 
were expressed as mean ± SD or mean ± SEM, when specified. Comparisons among multiple 
groups were made by the one-way analysis of variance or by Student t test. Statistical 
significance was established as *P < 0.05; **P < 0.01; ***P < 0.001. 
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Fig 1 
 
Mitochondrial localization of Foxg1. Immunocytochemical istribution of Foxg1 and Sod2 in 
representative confocal images of HN9.10e cells and primary glia. (A) HN9.10e cells 
expressing endogenous Foxg1. (B) HN9.10e cells transfected with untagged Foxg1. (C) Glial 
cells transfected with untagged Foxg1. (D–F) 2D histograms and colocalization patterns of 
Foxg1 and Sod2 in control cells and in cells overexpressing Foxg1; green and red indicate 
areas containing, respectively, Foxg1 alone or Sod2 alone; yellow represents areas that 
concurrently express both proteins (the enhancement of the mitochondrial low fluorescence 
results in a oversaturation of the nuclear compartment). (Scale bar, 10 µm.) 
 
 
 
  
Fig 2 
 
Foxg1-GFP and GFP-Foxg1 display different subcellular localizations. (A) Schematic 
representation of Foxg1-GFP and representative images of Foxg1-GFP-expressing cells 
loaded with TMRM. (B) Schematic representation of GFP-Foxg1 and representative images 
of GFP-Foxg1-expressing cells loaded with TMRM. Colocalization is indicated by yellow 
pixels in the merged images. (Scale bar, 5 µm.) 
 
 
 
  
Fig 3 
 
Imaging and WB assays on tagged and untagged Foxg1 overexpressing cells. (A) Schematic 
representation of CFP-Foxg1-YFP double-fusion protein and representative image of 
HN9.10e cells transiently transfected with the YFP-Foxg1-CFP construct. (Scale bar, 5 µm.) 
(B) WB assay on untransfected NIH 3T3 controls, GFP-Foxg1, and Foxg1-GFP 
overexpressing NIH 3T3 cells (whole lysate) processed 24 and 48 h after transfection; the 
filters were probed with an Ab against the Foxg1 C terminus. (C) WB assay on untransfected 
and untagged Foxg1-overexpressing NIH 3T3 cells (whole lysate) processed 24 and 48 h 
after transfection and probed with the same Ab as in B. See also Fig. S2 for schemes 
representing Foxg1 and its fluorescent fusion proteins. 
 
 
 
  
Fig 4 
 
Mitochondrial import assay in isolated rat liver mitochondria and Foxg1 subcellular 
localization in mouse brain. (A) Import assay of in vitro synthesized full-length and aa 272–
481 fragment of mouse Foxg1. Incubation of Foxg1 with isolated rat liver mitochondria in 
the absence (control) or presence of FCCP was followed by treatment with either trypsin or 
trypsin plus Triton X-100 and resolved in Bis-Tris SDS-PAGE. TnT reactions are also loaded 
as a control in each case (in FOXG1 272–481 the TnT lane contains a third of the amount 
incubated with mitochondria). (B) WB analysis of newborn mouse cortex subcellular 
fractions: total cortical lysate (Cortex), nuclei (Nuc), cytoplasm (Cyt), mitochondria (Mit), 
mitochondria treated with trypsin (mit+try), and mitochondria treated with trypsin and SDS 
(mit+try+SDS). 
 
 
 
 
  
Fig 5 
 
Cellular and mitochondrial morphology of HN9.10e cells overexpressing full-length and 
truncated Foxg1. (A) Exemplificative pictures of HN9.10e cells loaded with TMRM and 
expressing mt-Foxg1 (272–481) and cyt-Foxg1 (315–481) fused to GFP at their C terminus, 
and schematic representation of the constructs. (Scale bar, 5 µm.) (B) Distribution in three 
classes of length (<2 μm, 2–4 μm, or >4 μm) of mitochondria in HN9.10e cells transfected 
with either GFP alone or with GFP and untagged FL-Foxg1, mt-Foxg1 (272–481), or cyt-
Foxg1 (315–481). (C) Percentages of mitotic cells, blasts, and early differentiating cells in 
HN9.10e transfected with either GFP alone or with GFP and untagged FL-Foxg1, mt-Foxg1 
(272–481), or cyt-Foxg1 (315–481). T-test is referred to the GFP-transfected control sample. 
*P < 0.05, **P < 0.01, ***P < 0.001. 
 
 
 
 
  
Fig 6 
 
Mitochondrial membrane potential and cellular respiration in Foxg1-transfected HN9.10e 
cells. (A) Exemplificative pictures of untagged FL-Foxg1-expressing and mt-Foxg1-
expressing (272–481) HN9.10e cells, loaded with TMRM. (Scale bar, 5 µm.) (B) TMRM 
fluorescence changes upon oligomycin application in mitochondria of HN9.10e cells 
transiently transfected with either GFP alone (control) or GFP and untagged FL-Foxg1 (1–
481), mt-Foxg1 (272–481), or cyt-Foxg1 (315–481). Fluorescence was normalized to the 
mean TMRM fluorescence in control cells. (C and D) OCR normalized to OCR upon 
rotenone + antimycin A (nonmitochondrial OCR) of HN9.10e cells not transfected (wt) or 
transfected with FL-Foxg1, mt-Foxg1, or cyt-Foxg1. Cells have been challenged with 
oligomycin (C) or FCCP (D). Data represent mean ± SEM, n = 4 independent experiments, 
each condition replicated three to five times per experiment. (E) Quantification of the 
normalized OCR from C and D. *P < 0.05; **P < 0.01; ***P < 0.001. 
 
 
 
 
 
